verified SJR 0,986 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Taylor and Francis Ltd.

workspace_premium Q1 — Medicine (miscellaneous) lock Subscription

Expert Opinion on Drug Metabolism and Toxicology

Expert Opinion on Drug Metabolism and Toxicology is a journal indexed in SJR in Medicine (miscellaneous) and Pharmacology with an H index of 104. It has an SJR impact factor of 0,986 and it has a best quartile of Q1. It has an SJR impact factor of 0,986.

Expert Opinion on Drug Metabolism and Toxicology focuses its scope in these topics and keywords: drug, adme, studying, vivomodels, pathways, efficacy, clinical, cellular, effects, dialing, ...

ISSN: 1742-5255

Publisher: Taylor and Francis Ltd.

Category: Medicine (miscellaneous)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,986 Q1

H-index 104

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,986

H-index

104

Docs (year)

Docs 3y

256

Total refs

8232

Cites 3y

1030

Citable 3y

236

Cites/Doc 2y

2.94

Ref/Doc

87.57

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cell- and biomarker-based assays for predicting nephrotoxicity

Understanding the role of glycogen synthase kinase-3 in L-DOPA-induced dyskinesia in Parkinson's disease

Enhancement of drug absorption by noncharged detergents through membrane and P-glycoprotein binding

Drug-drug interactions between anti-retroviral therapies and drugs of abuse in HIV systems

Drug interactions with new hepatitis C oral drugs

Dose-toxicity models in oncology

Desloratadine and pseudoephedrine combination therapy as a comprehensive treatment for allergic rhinitis and nasal congestion

Current views on the fundamental mechanisms of cytochrome P450 allosterism

Current understanding of pharmacogenetic implications of DNA damaging drugs used in osteosarcoma treatment

Clinical implications ofCYP3Apolymorphisms

Clinical and pharmacokinetic evaluation of risperidone for the management of autism spectrum disorder

Cinacalcet: pharmacological and clinical aspects

SHOW MORE ARTICLES

Chemical activation of estrogen and aryl hydrocarbon receptor signaling pathways and their interaction in toxicology and metabolism

A decade of advances in metabonomics

Brentuximab vedotin for treating Hodgkin's lymphoma: an analysis of pharmacology and clinical efficacy

Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions

Assays for pharmacodynamic analysis of histone deacetylase inhibitors

An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding

An update on efflux and uptake transporters as determinants of statin response

An update on drug interaction considerations in the therapeutic use of carbonic anhydrase inhibitors

An evaluation of the pharmacokinetics of methylphenidate for the treatment of attention-deficit/ hyperactivity disorder

Advances in paediatric pharmacokinetics

Abuse-deterrent formulations: part 1 -development of a formulation-based classification system

ABCB1: the role in Parkinson's disease and pharmacokinetics of antiparkinsonian drugs

FAQs

Expert Opinion on Drug Metabolism and Toxicology has an SJR of 0,986 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Expert Opinion on Drug Metabolism and Toxicology is 25%.

Expert Opinion on Drug Metabolism and Toxicology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Expert Opinion on Drug Metabolism and Toxicology?

What is the APC / publication cost?

What is the acceptance rate?